FindTrial
Sign In

levels of Cell free DNA in malignant thyroid nodules

Cell free DNA as markers of malignancy in thyroid nodules - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/12/098345
Enrollment
200
Registered
2025-12-03
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E079- Disorder of thyroid, unspecified

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil

Sponsors

Dr Smita Sonoli
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Consecutive patients attending the endocrinology OPD

Exclusion criteria

Exclusion criteria: Hyperthyroidism with multi nodular disease on ultrasonography. Anaplastic cancer and medullary thyroid cancer. Patients with past/current history of any known malignancies.

Design outcomes

Primary

MeasureTime frame
To detect thyroid malignancies at an early stage, improving treatment outcomes and patient survival ratesTimepoint: 8 weeks—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactDr Smita Sonoli

KAHER Jawaharlal Nehru Medical College

naragundsmita@gmail.com09901662601

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026